IMPLEMENTING A VIRTUAL NEPHROLOGY PANEL FOR TOLVAPTAN USE IN PATIENTS WITH ADPKD

被引：0
|
作者：
Lin Duong [1 ]
Taneja, Nidhika [1 ]
Belani, Sharina [1 ]
Irannejad, Pardis [1 ]
Jain, Anagha [1 ]
Lieberman, Jonathan [1 ]
Tuan Nguyen [1 ]
Ramaswamy, Deepa [1 ]
机构：
[1] Kaiser Permanente Northern Calif, Oakland, CA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2021年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：590 / 590
页数：1
相关论文
共 50 条
  • [21] Real-life use of tolvaptan in ADPKD: a retrospective analysis of a large Canadian cohort
    Luca Calvaruso
    Kevin Yau
    Pedram Akbari
    Fatemah Nasri
    Saima Khowaja
    Bill Wang
    Amirreza Haghighi
    Korosh Khalili
    York Pei
    Scientific Reports, 13 (1)
  • [22] Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD
    Makabe, Shiho
    Manabe, Shun
    Kataoka, Hiroshi
    Akihisa, Taro
    Yoshida, Rie
    Ushio, Yusuke
    Sato, Masayo
    Tsuchiya, Ken
    Mochizuki, Toshio
    Nitta, Kosaku
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (09): : 2436 - 2444
  • [23] Real-life use of tolvaptan in ADPKD: a retrospective analysis of a large Canadian cohort
    Calvaruso, Luca
    Yau, Kevin
    Akbari, Pedram
    Nasri, Fatemah
    Khowaja, Saima
    Wang, Bill
    Haghighi, Amirreza
    Khalili, Korosh
    Pei, York
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [24] TOLVAPTAN REDUCES HEALTHCARE BURDEN IN PATIENTS WITH STAGE 1-3 ADPKD IN SPAIN
    Parramon Ponz, M.
    VALUE IN HEALTH, 2019, 22 : S914 - S915
  • [25] Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD
    Oporto, F. J. Roca
    Gomez, C. Andrades
    Cosano, G. Montilla
    Aguilera, A. Luna
    Rocha, Jose L.
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (04): : 1031 - 1039
  • [26] Author's Reply to Correspondence: "Effect of Tolvaptan Treatment on AcidLBase Homeostasis in ADPKD Patients"
    Heida, Judith E.
    Gansevoort, Ron T.
    Meijer, Esther
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (06): : 1749 - 1750
  • [27] The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD
    Geertsema, Paul
    Bais, Thomas
    Kuiken, Vera
    Knol, Martine G. E.
    Casteleijn, Niek F.
    Vart, Priya
    Meijer, Esther
    Gansevoort, Ron T.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [28] Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD
    Geertsema, Paul
    Soonawala, Darius
    Gansevoort, Ron T.
    Meijer, Esther
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (01): : 271 - 271
  • [29] Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD)
    Boyano, Iris Viejo
    Velasco, Paul Jose Hernandez
    Martinez, Eduardo Gutierrez
    NEFROLOGIA, 2024, 44 (02): : 301 - 303
  • [30] USE OF TOLVAPTAN IN INTENSIVE CARE PATIENTS
    Mimuro, S.
    Kimura, T.
    Naruse, S.
    Doi, M.
    Sato, S.
    INTENSIVE CARE MEDICINE, 2012, 38 : S174 - S174
12345